Literature DB >> 11592805

Dystrophin and muscular dystrophy: past, present, and future.

K F O'Brien1, L M Kunkel.   

Abstract

Duchenne muscular dystrophy was described in the medical literature in the early 1850s but the molecular basis of the disease was not determined until the late 1980s. The cloning of dystrophin led to the identification of a large complex of proteins that plays an important, although not yet well understood, role in muscle biology. Concomitant with the elucidation of the function of dystrophin and its associated proteins has been the pursuit of therapeutic options for muscular dystrophy. Although there is still no cure for this disorder, great advances are being made in the areas of gene introduction and cell transplant therapy. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592805     DOI: 10.1006/mgme.2001.3220

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  32 in total

1.  Recovery of electrogenesis in skeletal muscles after cell therapy of myodystrophy in MDX mice.

Authors:  V V Kravtsova; V M Mikhailov; A V Sokolova; E V Mikhailova; N A Timonina; E E Nikol'skii; I I Krivoi
Journal:  Dokl Biol Sci       Date:  2012-01-07

Review 2.  Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.

Authors:  Pedro Cisternas; Juan P Henriquez; Enrique Brandan; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2013-09-07       Impact factor: 5.590

Review 3.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

4.  ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.

Authors:  Pauliina Kronqvist; Nobuko Kawaguchi; Reidar Albrechtsen; Xiufeng Xu; Henrik Daa Schrøder; Behzad Moghadaszadeh; Finn Cilius Nielsen; Camilla Fröhlich; Eva Engvall; Ulla M Wewer
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Filamentous structures in skeletal muscle: anchors for the subsarcolemmal space.

Authors:  Astrid Feinisa Khairani; Yuki Tajika; Maiko Takahashi; Hitoshi Ueno; Tohru Murakami; Arifin Soenggono; Hiroshi Yorifuji
Journal:  Med Mol Morphol       Date:  2014-02-12       Impact factor: 2.309

6.  Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.

Authors:  Leonela Amoasii; Chengzu Long; Hui Li; Alex A Mireault; John M Shelton; Efrain Sanchez-Ortiz; John R McAnally; Samadrita Bhattacharyya; Florian Schmidt; Dirk Grimm; Stephen D Hauschka; Rhonda Bassel-Duby; Eric N Olson
Journal:  Sci Transl Med       Date:  2017-11-29       Impact factor: 17.956

7.  Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.

Authors:  Laurin M Hanft; Daniel J Bogan; Ulrike Mayer; Stephen J Kaufman; Joe N Kornegay; James M Ervasti
Journal:  Neuromuscul Disord       Date:  2007-05-01       Impact factor: 4.296

8.  Differential stabilities of alternative exon-skipped rod motifs of dystrophin.

Authors:  Chris Ruszczak; Ahmed Mirza; Nick Menhart
Journal:  Biochim Biophys Acta       Date:  2009-03-12

9.  AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice.

Authors:  Kristin N Heller; Chrystal L Montgomery; Paul Ml Janssen; K Reed Clark; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

10.  The dystrophin complex controls bk channel localization and muscle activity in Caenorhabditis elegans.

Authors:  Hongkyun Kim; Jonathan T Pierce-Shimomura; Hyun J Oh; Brandon E Johnson; Miriam B Goodman; Steven L McIntire
Journal:  PLoS Genet       Date:  2009-12-18       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.